Neos Therapeutics Inc (NEOS) Inventory Turnover Ratio, from third quarter 2020 to third quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Neos Therapeutics Inc   (NASDAQ: NEOS)
 

Neos Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Neos Therapeutics Inc inventory turnover ratio, the Neos Therapeutics Inc 's ability to sell and replace its inventory in the third quarter 2020, sequentially increased to 2.56 in the third quarter 2020, NEOS's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Neos Therapeutics Inc in Sep 30 2020 quarter, has decreased to 143 days, compare to 147 days, in the Jun 30 2020 quarter.

Within Healthcare sector 188 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2020, to 1459, from total ranking in the second quarter 2020 at 1488.

NEOS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neos Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEOS Inventory Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Inventory Growth -27.75 % -29.45 % -9.38 % 6.2 % -2.49 %
Y / Y Cost of Sales Growth -20.58 % 15.28 % -0.11 % -7.5 % -7.33 %
Inventory Turnover Ratio (TTM) 2.56 2.49 2.22 2.17 2.25
NEOS's Total Ranking # 1459 # 1488 # 1458 # 1458 # 1458
Average inventory processing period 143 147 165 168 162
Seq. Inventory Growth -3.37 % -14.56 % -7.19 % -5.7 % -5.64 %
Seq. Cost of Sales Growth -12.9 % -8 % -11.03 % 11.39 % 26.44 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 58
Healthcare Sector # 189
Overall Market # 1459

Inventory Turnover Ratio Statistics
High Average Low
3.3 2.18 0.43
(Mar 31 2016)   (Sep 30 2015)



NEOS Company Profile >> Back to NEOS Efficiency Comparisons >> Compare NEOS Inventory Turnover Ratio to its Competitors

Financial Statements
Neos Therapeutics Inc 's Inventories $ 8 Millions Visit NEOS's Balance sheet
Neos Therapeutics Inc 's Cost of Revenues TTM $ 25 Millions Visit NEOS's Income Statement
What are NEOS's Sales? Visit NEOS's Sales by Segment

Other Inventory Turnover Ratios
Neos Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NEOS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NEOS's Competitors
Inventory Turnover Ratio for NEOS's Suppliers
Inventory Turnover Ratio for NEOS's Customers

You may also want to know
NEOS's Sales Growth Rates NEOS's Pe Price to earnings ratio NEOS's Receivables Turnover Ratio NEOS's Stock Quote
NEOS's Net Income Growth Rates NEOS's Ps Price to Sales ratio NEOS's Sales per Employee NEOS's Asset Turnover Ratio
NEOS's Net Margin NEOS's Pb Price to Book ratio NEOS's Financial Strength Ratios NEOS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2020 Inventories at quarter ending Sep 30 2020
Surgery Partners Inc   7.95 $ 388.000  Millions$ 49  Millions
Caredx Inc   7.82 $ 61.766  Millions$ 8  Millions
Perspective Therapeutics Inc   7.70 $ 4.615  Millions$ 1  Millions
Kewaunee Scientific Corporation  7.69 $ 121.464  Millions$ 16  Millions
Lifemd Inc   7.62 $ 7.942  Millions$ 1  Millions
Dmk Pharmaceuticals Corporation  7.39 $ 16.216  Millions$ 2  Millions
Catalent Inc   7.08 $ 2,220.800  Millions$ 314  Millions
Horizon Therapeutics Public Limited Company  7.02 $ 465.327  Millions$ 66  Millions
Ufp Technologies Inc   6.96 $ 137.410  Millions$ 20  Millions
Enzo Biochem Inc  6.92 $ 54.488  Millions$ 8  Millions
Catalyst Pharmaceuticals Inc   6.81 $ 18.280  Millions$ 3  Millions
Align Technology inc   6.64 $ 809.353  Millions$ 122  Millions
Healthlynked Corp  6.57 $ 0.609  Millions$ 0  Millions
Genmark Diagnostics Inc   6.53 $ 91.007  Millions$ 14  Millions
Clearday Inc   6.51 $ 0.760  Millions$ 0  Millions
Sunshine Biopharma Inc   6.29 $ 0.114  Millions$ 0  Millions
Fonar Corporation  6.13 $ 10.538  Millions$ 2  Millions
Stablecoin Development Corporation  6.11 $ 3.750  Millions$ 1  Millions
Nexgel Inc   6.04 $ 0.831  Millions$ 0  Millions
Carlisle Companies Incorporated  5.86 $ 3,126.800  Millions$ 533  Millions
Avid Bioservices Inc   5.85 $ 58.143  Millions$ 10  Millions
Camp4 Therapeutics Corporation  5.81 $ 215.468  Millions$ 37  Millions
Avantor Inc   5.77 $ 4,133.600  Millions$ 716  Millions
Lantheus Holdings Inc   5.71 $ 189.929  Millions$ 33  Millions
Patterson Companies Inc   5.55 $ 4,361.575  Millions$ 785  Millions
Aquestive Therapeutics Inc   5.49 $ 16.968  Millions$ 3  Millions
Myriad Genetics Inc   5.30 $ 156.200  Millions$ 29  Millions
Cytosorbents Corporation  5.25 $ 10.620  Millions$ 2  Millions
Idexx Laboratories Inc  5.17 $ 1,102.705  Millions$ 213  Millions
Inogen Inc   5.06 $ 175.383  Millions$ 35  Millions

Date modified: 2026-08-29T17:32:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.